Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.95
-0.06 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
9.96
+0.01 (0.10%)
After-hours: Apr 28, 2026, 4:11 PM EDT
Bioventus Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 830 | 498 | 686 | 332 | 162 | 861 | |
| Market Cap Growth | 67.74% | -27.40% | 106.84% | 105.22% | -81.23% | - | |
| Enterprise Value | 1,091 | 838 | 1,086 | 775 | 605 | 1,054 | |
| Last Close Price | 9.96 | 7.44 | 10.50 | 5.27 | 2.61 | 14.49 | |
| PE Ratio | 30.15 | 21.92 | - | - | - | - | |
| Forward PE | 13.30 | 9.79 | 20.00 | 21.82 | 17.17 | 21.50 | |
| PS Ratio | 1.46 | 0.88 | 1.20 | 0.65 | 0.32 | 2.00 | |
| PB Ratio | 3.63 | 2.18 | 3.70 | 1.50 | 0.39 | 1.61 | |
| P/FCF Ratio | 11.52 | 6.91 | 18.16 | 41.57 | - | 90.94 | |
| P/OCF Ratio | 11.12 | 6.67 | 17.69 | 21.63 | - | 37.46 | |
| PEG Ratio | 1.21 | - | - | - | - | 2.07 | |
| EV/Sales Ratio | 1.92 | 1.48 | 1.90 | 1.51 | 1.18 | 2.45 | |
| EV/EBITDA Ratio | 14.05 | 10.80 | 19.48 | 26.88 | - | 25.38 | |
| EV/EBIT Ratio | 19.36 | 14.88 | 29.66 | 382.69 | - | 50.07 | |
| EV/FCF Ratio | 15.12 | 11.63 | 28.75 | 97.14 | - | 111.28 | |
| Debt / Equity Ratio | 1.36 | 1.36 | 1.92 | 1.90 | 1.06 | 0.71 | |
| Debt / EBITDA Ratio | 3.74 | 3.74 | 5.79 | 11.81 | 719.64 | 8.23 | |
| Debt / FCF Ratio | 4.32 | 4.32 | 9.42 | 52.70 | - | 39.72 | |
| Net Debt / Equity Ratio | 1.14 | 1.14 | 1.69 | 1.74 | 0.99 | 0.62 | |
| Net Debt / EBITDA Ratio | 3.35 | 3.35 | 5.64 | 13.30 | -86.70 | 8.00 | |
| Net Debt / FCF Ratio | 3.61 | 3.61 | 8.32 | 48.07 | -16.20 | 35.09 | |
| Asset Turnover | 0.81 | 0.81 | 0.75 | 0.47 | 0.39 | 0.50 | |
| Inventory Turnover | 2.06 | 2.06 | 2.01 | 2.09 | 2.47 | 2.82 | |
| Quick Ratio | 1.12 | 1.12 | 0.80 | 0.91 | 0.55 | 0.93 | |
| Current Ratio | 1.70 | 1.70 | 1.31 | 1.53 | 0.90 | 1.46 | |
| Return on Equity (ROE) | 13.17% | 13.17% | -23.14% | -38.27% | -30.58% | 3.38% | |
| Return on Assets (ROA) | 4.99% | 4.99% | 2.97% | 0.12% | -1.67% | 1.53% | |
| Return on Invested Capital (ROIC) | 11.33% | 11.40% | 6.63% | 0.29% | -4.12% | 3.73% | |
| Return on Capital Employed (ROCE) | 10.80% | 10.80% | 7.10% | 0.30% | -3.20% | 2.00% | |
| Earnings Yield | 2.74% | 4.56% | -5.26% | -47.08% | -98.15% | 2.25% | |
| FCF Yield | 8.68% | 14.47% | 5.51% | 2.40% | -15.50% | 1.10% | |
| Buyback Yield / Dilution | -6.77% | -6.77% | -3.03% | -2.05% | -35.00% | -828.01% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.